Rehabilitative interventions in patients with persistent post COVID-19 symptoms-a review of recent advances and future perspectives.
Long-COVID
Rehabilitation
SARS-CoV-2
Therapy
Treatment
Journal
European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030
Informations de publication
Date de publication:
16 Jun 2023
16 Jun 2023
Historique:
received:
27
03
2023
accepted:
29
05
2023
medline:
16
6
2023
pubmed:
16
6
2023
entrez:
16
6
2023
Statut:
aheadofprint
Résumé
The SARS-CoV-2 pandemic has not only caused millions of deaths but left also millions of people with persistent symptoms behind. These long-term COVID-19 sequelae cause a considerable burden on individuals´ health, healthcare systems, and economies worldwide given the high rate of SARS-CoV-2 infections. Therefore, rehabilitative interventions and strategies are needed to counteract the post COVID-19 sequelae. The importance of rehabilitation for patients with persistent COVID-19 symptoms has been recently also highlighted in a Call for Action by the World Health Organisation. Based on previously published research, but also in line with clinical experience, COVID-19 is not one specific disease but rather presents in different phenotypes that vary in their pathophysiological mechanisms, symptomatic manifestations, and potential interventional approaches. This review provides a proposal for differentiating post COVID-19 patients in non-organ-specific phenotypes that may help clinicians to evaluate patients and to plan therapeutic options. Furthermore, we present current unmet needs and suggest a potential pathway for a specific rehabilitation approach in people with persistent post-COVID symptoms.
Identifiants
pubmed: 37326700
doi: 10.1007/s00406-023-01631-9
pii: 10.1007/s00406-023-01631-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
WHO Coronavirus Dashboard available at https://covid19.who.int/ Accessed on 01 Mar 2023.
C-EM Collaborators (2022) Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality. Lancet 399:1513–1536
doi: 10.1016/S0140-6736(21)02796-3
Smith MP (2022) Estimating total morbidity burden of COVID-19: relative importance of death and disability. J Clin Epidemiol 142:54–59
pubmed: 34715312
doi: 10.1016/j.jclinepi.2021.10.018
Briggs AH, Goldstein DA, Kirwin E et al (2021) Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19. Health Econ 30:699–707
pubmed: 33368853
doi: 10.1002/hec.4208
https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition ; Accessed on 30 Jan 2023.
Chen C, Haupert SR, Zimmermann L et al (2022) Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis 226:1593–1607
pubmed: 35429399
doi: 10.1093/infdis/jiac136
Sudre CH, Murray B, Varsavsky T et al (2021) Attributes and predictors of long COVID. Nat Med 27:626–631
pubmed: 33692530
pmcid: 7611399
doi: 10.1038/s41591-021-01292-y
Perlis RH, Santillana M, Ognyanova K et al (2022) Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw Open 5:e2238804
pubmed: 36301542
pmcid: 9614581
doi: 10.1001/jamanetworkopen.2022.38804
NIHR-National Institute for Health Research. Living with COVID19 second Review_16.03.2021. DOI: https://doi.org/10.3310/themedreview_45225 .
Antonelli M, Pujol JC, Spector TD et al (2022) Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet 399:2263–2264
pubmed: 35717982
pmcid: 9212672
doi: 10.1016/S0140-6736(22)00941-2
Ballering AV, van Zon SKR, Olde Hartman TC et al (2022) Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400:452–461
pubmed: 35934007
pmcid: 9352274
doi: 10.1016/S0140-6736(22)01214-4
Cutler DM (2022) The Costs of Long COVID. JAMA Health Forum 3:e221809
pubmed: 36219031
doi: 10.1001/jamahealthforum.2022.1809
Kluge HHP, Muscat NA, Mishra S et al (2022) Call for action: Health services in the European region must adopt integrated care models to manage Post-Covid-19 Condition. Lancet Reg Health Eur 18:100435
pubmed: 35756854
pmcid: 9217062
doi: 10.1016/j.lanepe.2022.100435
Yong SJ, Liu S (2022) Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 32:e2315
pubmed: 34888989
doi: 10.1002/rmv.2315
Davis HE, Assaf GS, McCorkell L et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMed 38:101019
doi: 10.1016/j.eclinm.2021.101019
Nguyen NN, Hoang VT, Dao TL et al (2022) Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review. Eur J Clin Microbiol Infect Dis 41:515–545
pubmed: 35142947
pmcid: 8830952
doi: 10.1007/s10096-022-04417-4
Louis TJ, Qasem A, Abdelli LS et al (2022) Extra-pulmonary complications in SARS-CoV-2 infection: a comprehensive multi organ-system review. Microorganisms. 10:153
pubmed: 35056603
pmcid: 8781813
doi: 10.3390/microorganisms10010153
Proal AD, VanElzakker MB (2021) Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 12:698169
pubmed: 34248921
pmcid: 8260991
doi: 10.3389/fmicb.2021.698169
Augustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 6:100122
pubmed: 34027514
pmcid: 8129613
doi: 10.1016/j.lanepe.2021.100122
Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS et al (2022) Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry 11:1–15
Hickie I, Davenport T, Wakefield D et al (2006) Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 333:575
pubmed: 16950834
pmcid: 1569956
doi: 10.1136/bmj.38933.585764.AE
Soares MN, Eggelbusch M, Naddaf E et al (2022) Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J Cachexia Sarcopenia Muscle 13:11–22
pubmed: 34997689
pmcid: 8818659
doi: 10.1002/jcsm.12896
Fresard I, Genecand L, Altarelli M et al (2022) Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in “long COVID” patients with persistent dyspnoea. BMJ Open Respir Res 9:e001126
pubmed: 35354589
pmcid: 8968537
doi: 10.1136/bmjresp-2021-001126
Motiejunaite J, Balagny P, Arnoult F et al (2021) Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur Respir J 58:2101578
pubmed: 34385265
pmcid: 8361302
doi: 10.1183/13993003.01578-2021
Regmi B, Friedrich J, Jorn B et al (2023) Diaphragm muscle weakness might explain exertional dyspnea fifteen months after hospitalization for COVID-19. Am J Respir Crit Care Med 207:1012
pubmed: 36596223
pmcid: 10112448
doi: 10.1164/rccm.202206-1243OC
Douaud G, Lee S, Alfaro-Almagro F et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604:697–707
pubmed: 35255491
pmcid: 9046077
doi: 10.1038/s41586-022-04569-5
Nacul L, Authier FJ, Scheibenbogen C et al (2021) European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina (Kaunas) 57:510
pubmed: 34069603
doi: 10.3390/medicina57050510
WHO. 2023 Clinical management of COVID-19: Living guideline. January.
Fan Y, Shi Y, Zhang J et al (2021) The effects of narrative exposure therapy on COVID-19 patients with post-traumatic stress symptoms: a randomized controlled trial. J Affect Disord 293:141–147
pubmed: 34186232
pmcid: 8234566
doi: 10.1016/j.jad.2021.06.019
Holland AE, Hill CJ, Jones AY et al (2012) Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 10:008250
Spruit MA, Singh SJ, Garvey C et al (2013) An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188:e13-64
pubmed: 24127811
doi: 10.1164/rccm.201309-1634ST
Liu K, Zhang W, Yang Y et al (2020) Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Compl Ther Clin Pract 39:101166
doi: 10.1016/j.ctcp.2020.101166
McNarry MA, Berg RMG, Shelley J et al (2022) Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J 60:2103101
pubmed: 35236727
pmcid: 8900538
doi: 10.1183/13993003.03101-2021
Gloeckl R, Leitl D, Jarosch I et al (2021) Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res 7:00108–02021
pubmed: 34095290
pmcid: 7957293
doi: 10.1183/23120541.00108-2021
Nopp S, Moik F, Klok FA et al (2022) Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration 101:593–601
pubmed: 35203084
doi: 10.1159/000522118
Swarnakar R, Yadav SL (2022) Rehabilitation in long COVID-19: A mini-review. World J Methodol 12:235–245
pubmed: 36159093
pmcid: 9350732
doi: 10.5662/wjm.v12.i4.235
Amini A, Vaezmousavi M, Shirvani H (2022) The effectiveness of cognitive-motor training on reconstructing cognitive health components in older male adults, recovered from the COVID-19. Neurol Sci 43:1395–1403
pubmed: 34328579
doi: 10.1007/s10072-021-05502-w
Whitcroft KL, Hummel T (2020) Olfactory dysfunction in COVID-19: diagnosis and management. JAMA 323:2512–2514
pubmed: 32432682
doi: 10.1001/jama.2020.8391
Deumer US, Varesi A, Floris V et al (2021) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview. J Clin Med 10:4786
pubmed: 34682909
pmcid: 8538807
doi: 10.3390/jcm10204786
Bested AC, Marshall LM (2015) Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health 30:223–249
pubmed: 26613325
doi: 10.1515/reveh-2015-0026
Ormiston CK, Swiatkiewicz I, Taub PR (2022) Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm 19:1880–1889
pubmed: 35853576
pmcid: 9287587
doi: 10.1016/j.hrthm.2022.07.014
Spahic JM, Hamrefors V, Johansson M et al (2023) Malmo POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome. J Intern Med 293:91–99
pubmed: 36111700
doi: 10.1111/joim.13566
NICE Guideline - Myalgic encephalomyelitis /chronic fatigue syndrome: diagnosis and management. Published: 29 October 2021 www.nice.org.uk/guidance/ng206
Cotler J, Holtzman C, Dudun C et al (2018) A brief questionnaire to assess post-exertional malaise. Diagnostics (Basel). 8:332
Parker M, Sawant HB, Flannery T et al (2023) Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome. J Med Virol 95:e28373
pubmed: 36461167
doi: 10.1002/jmv.28373
Heald A, Barber L, Jones HL et al (2019) Service based comparison of group cognitive behavior therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions. Medicine (Baltimore) 98:e16720
pubmed: 31574792
doi: 10.1097/MD.0000000000016720
Geraghty KJ, Blease C (2018) Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent. J Health Psychol 23:127–138
pubmed: 27634687
doi: 10.1177/1359105316667798
Hirawat R, Jain N, Aslam Saifi M et al (2022) Lung fibrosis: Post-COVID-19 complications and evidences. Int Immunopharmacol 116:109418
pubmed: 36736220
pmcid: 9633631
doi: 10.1016/j.intimp.2022.109418
Hama Amin BJ, Kakamad FH, Ahmed GS et al (2022) Post COVID-19 pulmonary fibrosis; a meta-analysis study. Ann Med Surg (Lond) 77:103590
pubmed: 35411216
Luger AK, Sonnweber T, Gruber L et al (2022) Chest CT of lung injury 1 year after COVID-19 pneumonia: the CovILD study. Radiology 304:462–470
pubmed: 35348379
doi: 10.1148/radiol.211670
Nanwani-Nanwani K, Lopez-Perez L, Gimenez-Esparza C et al (2022) Prevalence of post-intensive care syndrome in mechanically ventilated patients with COVID-19. Sci Rep 12:7977
pubmed: 35562379
pmcid: 9105588
doi: 10.1038/s41598-022-11929-8
Inoue S, Hatakeyama J, Kondo Y et al (2019) Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg 6:233–246
pubmed: 31304024
pmcid: 6603316
doi: 10.1002/ams2.415
Bain W, Yang H, Shah FA et al (2021) COVID-19 versus Non-COVID-19 acute respiratory distress syndrome: comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes. Ann Am Thorac Soc 18:1202–1210
pubmed: 33544045
pmcid: 8328355
doi: 10.1513/AnnalsATS.202008-1026OC
Singh P, Behera D, Gupta S et al (2022) Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: a single-centre study. J R Coll Physicians Edinb 52:100–104
pubmed: 36146989
doi: 10.1177/14782715221103402
Goodwin VA, Allan L, Bethel A et al (2021) Rehabilitation to enable recovery from COVID-19: a rapid systematic review. Physiotherapy 111:4–22
pubmed: 33637294
pmcid: 7902208
doi: 10.1016/j.physio.2021.01.007
Dowman L, Hill CJ, May A et al (2021) Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2:006322
Al Chikhanie Y, Veale D, Schoeffler M et al (2021) Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respir Physiol Neurobiol 287:103639
pubmed: 33588090
pmcid: 7879818
doi: 10.1016/j.resp.2021.103639
Nath A (2020) Long-Haul COVID. Neurology 95:559–560
pubmed: 32788251
doi: 10.1212/WNL.0000000000010640
Hacker KA, Briss PA, Richardson L et al (2021) COVID-19 and chronic disease: the impact now and in the future. Prev Chronic Dis 18:E62
pubmed: 34138696
pmcid: 8220960
doi: 10.5888/pcd18.210086
Al-Aly Z, Xie Y, Bowe B (2021) High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594:259–264
pubmed: 33887749
doi: 10.1038/s41586-021-03553-9
Ayoubkhani D, Khunti K, Nafilyan V et al (2021) Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 372:n693
pubmed: 33789877
doi: 10.1136/bmj.n693
Rathmann W, Kuss O, Kostev K (2022) Incidence of newly diagnosed diabetes after Covid-19. Diabetologia 65:949–954
pubmed: 35292829
pmcid: 8923743
doi: 10.1007/s00125-022-05670-0
Matta J, Wiernik E, Robineau O et al (2022) Association of Self-reported COVID-19 Infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med 182:19–25
pubmed: 34747982
doi: 10.1001/jamainternmed.2021.6454
Han Q, Zheng B, Daines L et al (2022) Long-Term Sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens 11:269
pubmed: 35215212
pmcid: 8875269
doi: 10.3390/pathogens11020269
Mizrahi B, Sudry T, Flaks-Manov N et al (2023) Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380:e072529
pubmed: 36631153
doi: 10.1136/bmj-2022-072529
Rahmati M, Molanouri Shamsi M, Woo W et al (2023) Effects of physical rehabilitation interventions in COVID-19 patients following discharge from hospital: a systematic review. J Integr Med 21:149
pubmed: 36717302
pmcid: 9851951
doi: 10.1016/j.joim.2023.01.003
Jimeno-Almazan A, Franco-Lopez F, Buendia-Romero A et al (2022) Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: a randomized controlled trial. Scand J Med Sci Sports 32:1791–1801
pubmed: 36111386
doi: 10.1111/sms.14240
Llurda-Almuzara L, Rodriguez-Sanz J, Lopez-de-Celis C et al (2022) Effects of adding an online exercise program on physical function in individuals hospitalized by COVID-19: a randomized controlled trial. Int J Environ Res Public Health 19:16619
pubmed: 36554510
pmcid: 9778879
doi: 10.3390/ijerph192416619
Li J, Xia W, Zhan C et al (2022) A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax 77:697–706
pubmed: 34312316
doi: 10.1136/thoraxjnl-2021-217382
Del Corral T, Fabero-Garrido R, Plaza-Manzano G et al (2023) Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-COVID-19: Randomized controlled trial. Ann Phys Rehabil Med 66:101709
pubmed: 36191860
doi: 10.1016/j.rehab.2022.101709
Sahin H, Naz I, Karadeniz G et al (2023) Effects of a home-based pulmonary rehabilitation program with and without telecoaching on health-related outcomes in COVID-19 survivors: a randomized controlled clinical study. J Bras Pneumol 49:e20220107
pubmed: 36700571
Gloeckl R, Leitl D, Jarosch I et al (2021) Pulmonary rehabilitation in long COVID: more than just natural recovery!? ERJ Open Res 7:454
doi: 10.1183/23120541.00454-2021
Lindsay RK, Wilson JJ, Trott M et al (2021) What are the recommendations for returning athletes who have experienced long term COVID-19 symptoms? Ann Med 53:1935–1944
pubmed: 34726085
pmcid: 8567919
doi: 10.1080/07853890.2021.1992496
DeMars J, Brown DA, Angelidis I et al (2022) What is Safe Long COVID Rehabilitation? J Occup Rehabil 53:1–4
Callard F, Perego E (2021) How and why patients made Long Covid. Soc Sci Med 268:113426
pubmed: 33199035
pmcid: 7539940
doi: 10.1016/j.socscimed.2020.113426
Mehra VM, Gaalema DE, Pakosh M et al (2020) Systematic review of cardiac rehabilitation guidelines: Quality and scope. Eur J Prev Cardiol 27:912–928
pubmed: 31581808
doi: 10.1177/2047487319878958
Berentschot JC, Heijenbrok-Kal MH, Bek LM et al (2022) Physical recovery across care pathways up to 12 months after hospitalization for COVID-19: A multicenter prospective cohort study (CO-FLOW). Lancet Reg Health Eur 22:100485
pubmed: 36039177
pmcid: 9402257
doi: 10.1016/j.lanepe.2022.100485
Decary S, De Groote W, Arienti C et al (2022) Scoping review of rehabilitation care models for post COVID-19 condition. Bull World Health Organ 100:676–688
pubmed: 36324552
pmcid: 9589389
doi: 10.2471/BLT.22.288105
Marshall-Andon T, Walsh S, Berger-Gillam T et al (2023) Systematic review of post-COVID-19 syndrome rehabilitation guidelines. Integ Healthcare J 4:e000100
Negrini S, Borg K, Cusick A et al (2023) Global Statements to produce and implement evidence in the post-COVID-19 era provide a path forward for rehabilitation - a joint initiative of cochrane rehabilitation and the leading journals in the field. Am J Phys Med Rehabil 102:e26–e31
pubmed: 36796420
pmcid: 9940826
doi: 10.1097/PHM.0000000000002155